AI's transformative impact on medicine, explored by Ryan Stidham, MD, reveals potential applications in dermatology, emphasizing caution, ethical considerations, and the need for collaboration across specialties.

Investigators revealed the development of a non-invasive molecular test utilizing gene expression differences in skin diseases such as atopic dermatitis, psoriasis, and mycosis fungoides, with the potential to accurately diagnose and identify super-responders to targeted systemic therapies.

Alice Gottlieb, MD, PhD, put a spotlight on recent studies and the current psoriasis treatment armamentarium for dermatology clinicians to consider.

Susan Taylor, MD, provided insight into epidemiology, patient quality of life, clinical presentation, therapies, and more at Masterclasses in Dermatology.

Peter Lio, MD, shared alternative medicine approaches and resources that dermatologists and patients can utilize for various skin conditions.

The 2-GEP test is made of 2 biomarkers, LINC00518 and PRAME.

Learn what makes the Masterclasses in Dermatology conference a unique educational opportunity, and take a quick poll to tell us what you want to learn.

Among the many sessions to be held at the Winter Clinical Miami 2024 Conference in Miami Beach, Florida, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll about the upcoming conference.

Click here to answer our poll about the upcoming conference in Puerto Rico.

Interim data from the clinical trial was presented in a poster at the South Beach Symposium, with itch reduction demonstrating immediacy and long-term capability.

The conference's course directors give a sneak peek of what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.

Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.

Ablon’s session highlights include best practices for hair restoration.

Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study.

An immunosuppressed patient with refractory plantar warts showed improvement following cantharidinpodophyllotoxin-salicylic acid (CPS) monotherapy.

Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.

Let us know if you plan to attend IMCAS World Congress 2024.

A poster analyzing the BRAVE-AA study population was presented at Maui Derm Hawaii 2024.